{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:08:54Z","timestamp":1761761334452,"version":"build-2065373602"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,9,10]],"date-time":"2007-09-10T00:00:00Z","timestamp":1189382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the significance of viable tumour in the prostate of patients with metastatic androgen\u2010independent prostate cancer (AIPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>We evaluated the clinicopathological features, including follow\u2010up, of 40 men with metastatic AIPC who had a transrectal biopsy of the prostate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Prostate biopsies (median three cores per biopsy) showed viable tumour in 19 of 40 patients (48%). Of the 18 patients who had received radiotherapy (RT), nine had negative on\u2010study biopsy results. A previous history of RT was not associated with overall survival in patients with biopsy\u2010positive tumours (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003=\u20030.84). Also, there was no statistically significant association between positive or negative biopsy status and overall survival (OS) in these 40 patients (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003=\u20030.39), with a similar median OS of 19.6\u2003months for biopsy\u2010negative and 19.8\u2003months for biopsy\u2010positive patients, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Taking prostate biopsies at the time of documented metastatic AIPC yielded tumour in about half the patients. A previous history of RT was not associated with a negative prostate biopsy; the latter appears to have no influence on the prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2007.07173.x","type":"journal-article","created":{"date-parts":[[2007,9,16]],"date-time":"2007-09-16T01:24:28Z","timestamp":1189905868000},"page":"1245-1248","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer"],"prefix":"10.1111","volume":"100","author":[{"given":"Jeanny B.","family":"Aragon\u2010Ching","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas K.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Chuaqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Rodriguez\u2010Canales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Dahut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,10]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90108-F"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.2906"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35410-1"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09380-4"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-004-0443-7"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199102000-00002"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.51.1.5"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200211000-00002"},{"key":"e_1_2_8_10_2","first-page":"1888","article-title":"A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen\u2010independent prostate cancer","volume":"7","author":"Figg WD","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.074"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_8_13_2","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel N","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01423-1"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00748-X"},{"key":"e_1_2_8_16_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/2007-131-360-DOPCAT","article-title":"Diagnosis of prostatic carcinoma after therapy: Review","volume":"131","author":"Bostwick DG","year":"2007","journal-title":"Arch Pathol Laboratory Med"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)02670-0"},{"key":"e_1_2_8_18_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-5347(17)56536-2","article-title":"The ultrastructural changes of prostate adenocarcinoma following external beam radiation therapy","volume":"122","author":"Kiesling VJ","year":"1979","journal-title":"J Urol"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45712-0"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)00637-4"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603274"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2007.07173.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2007.07173.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:04:16Z","timestamp":1761761056000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2007.07173.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,10]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1464-410X.2007.07173.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2007.07173.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2007,9,10]]},"assertion":[{"value":"2007-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}